Infectious encephalitis

Summary

Infectious encephalitis (MONDO:0020067) is a disease (an umbrella term covering 10 Mondo subtypes) and 3 clinical trials. A subtype of encephalitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Umbrella term: 10 Mondo subtypes
• Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	infectious encephalitis
Mondo ID	MONDO:0020067
MeSH	D000069544
NCIT	C79550
SNOMED CT	312215006
UMLS	C0596773
MedGen	108917
GARD	0025151
Is cancer (heuristic)	no

Also known as: encephalitis infection

Disease family

This is a subtype of encephalitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › encephalomyelitis › encephalitis › infectious encephalitis

Related subtypes (6): post-vaccinal encephalitis, meningoencephalitis, limbic encephalitis, autoimmune encephalitis, anti-NMDA receptor encephalitis, paraneoplastic isolated brainstem encephalitis

Subtypes (10): primary amebic meningoencephalitis, granulomatous amebic encephalitis, syphilitic encephalitis, Kluver-Bucy syndrome, viral encephalitis, progressive multifocal leukoencephalopathy, acute necrotizing encephalopathy of childhood, Hendra virus infection, Mycoplasma encephalitis, postinfectious encephalitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	2
PHASE1	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT03776994	PHASE1	UNKNOWN	Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine
NCT06820060	Not specified	ACTIVE_NOT_RECRUITING	Clinical Performance of QIAstat-Dx® Meningitis/Encephalitis (ME) Panel Plus
NCT06593249	Not specified	COMPLETED	Management of Tick-borne Encephalitis